Cargando…

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model

Mostrar otras versiones (1)

The COVID-19 pandemic progresses unabated in many regions of the world. An effective antiviral against SARS-CoV-2 that could be administered orally for use following high-risk exposure would be of substantial benefit in controlling the COVID-19 pandemic. Herein, we show that MK-4482, an orally admin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenke, Kyle, Hansen, Frederick, Schwarz, Benjamin, Feldmann, Friederike, Haddock, Elaine, Rosenke, Rebecca, Meade-White, Kimberly, Okumura, Atsushi, Leventhal, Shanna, Hawman, David W., Ricotta, Emily, Bosio, Catharine M., Saturday, Greg, Feldmann, Heinz, Jarvis, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553153/ https://www.ncbi.nlm.nih.gov/pubmed/33052329 http://dx.doi.org/10.21203/rs.3.rs-86289/v1

Ejemplares similares

Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model
por: Rosenke, Kyle, et al.
Publicado: (2021)

Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
por: Rosenke, Kyle, et al.
Publicado: (2022)

SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract
por: Hansen, Frederick, et al.
Publicado: (2022)

Histopathologic Characterization of Experimental Peracute SARS-CoV-2 Infection in the Syrian Hamster
por: Clancy, Chad S., et al.
Publicado: (2023)

Hydroxychloroquine Proves Ineffective in Hamsters and Macaques Infected with SARS-CoV-2
por: Rosenke, Kyle, et al.
Publicado: (2020)

Identifying Early Target Cells of Nipah Virus Infection in Syrian Hamsters
por: Baseler, Laura, et al.
Publicado: (2016)

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models
por: Rosenke, Kyle, et al.
Publicado: (2020)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020)

Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection
por: Rosenke, Kyle, et al.
Publicado: (2020)

Pathogenesis and Host Response in Syrian Hamsters following Intranasal Infection with Andes Virus
por: Safronetz, David, et al.
Publicado: (2011)

An Intramuscular DNA Vaccine for SARS-CoV-2 Decreases Viral Lung Load but Not Lung Pathology in Syrian Hamsters
por: Leventhal, Shanna S., et al.
Publicado: (2021)

Molnupiravir inhibits SARS-CoV-2 variants including Omicron in the hamster model
por: Rosenke, Kyle, et al.
Publicado: (2022)

Domestic Pig Unlikely Reservoir for MERS-CoV
por: de Wit, Emmie, et al.
Publicado: (2017)

Combined molnupiravir-nirmatrelvir treatment improves the inhibitory effect on SARS-CoV-2 in macaques
por: Rosenke, Kyle, et al.
Publicado: (2023)

Combined Molnupiravir and Nirmatrelvir Treatment Improves the Inhibitory Effect on SARS-CoV-2 in Rhesus Macaques
por: Rosenke, Kyle, et al.
Publicado: (2022)

Immunocompetent mouse model for Crimean-Congo hemorrhagic fever virus
por: Hawman, David W, et al.
Publicado: (2021)

T-Cells and Interferon Gamma Are Necessary for Survival Following Crimean-Congo Hemorrhagic Fever Virus Infection in Mice
por: Hawman, David W., et al.
Publicado: (2021)

A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)

Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine
por: Hawman, David W., et al.
Publicado: (2022)

Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus)
por: Zivcec, Marko, et al.
Publicado: (2011)

Mastomys natalensis Has a Cellular Immune Response Profile Distinct from Laboratory Mice
por: Tang-Huau, Tsing-Lee, et al.
Publicado: (2021)

A Look into Bunyavirales Genomes: Functions of Non-Structural (NS) Proteins
por: Leventhal, Shanna S., et al.
Publicado: (2021)

Lassa Virus Treatment Options
por: Hansen, Frederick, et al.
Publicado: (2021)

CD8(+) T-cells target the Crimean-Congo haemorrhagic fever virus Gc protein to control the infection in wild-type mice
por: Rao, Deepashri, et al.
Publicado: (2023)

Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021)

Foodborne Transmission of Nipah Virus in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2014)

Therapeutic MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets
por: Cox, Robert M., et al.
Publicado: (2020)

Alkhurma haemorrhagic fever virus causes lethal disease in IFNAR(-/-) mice
por: Bhatia, Bharti, et al.
Publicado: (2021)

Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge
por: Leventhal, Shanna S., et al.
Publicado: (2022)

Progress Toward a Large-Scale Synthesis of Molnupiravir (MK-4482, EIDD-2801) from Cytidine
por: Ahlqvist, Grace P., et al.
Publicado: (2021)

Single low-dose VSV-EBOV vaccination protects cynomolgus macaques from lethal Ebola challenge
por: Marzi, Andrea, et al.
Publicado: (2019)

Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational study
por: Matson, M Jeremiah, et al.
Publicado: (2022)

Sequencing, Annotation and Analysis of the Syrian Hamster (Mesocricetus auratus) Transcriptome
por: Tchitchek, Nicolas, et al.
Publicado: (2014)

UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates
por: Rosenke, K., et al.
Publicado: (2021)

The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Does Not Replicate in Syrian Hamsters
por: de Wit, Emmie, et al.
Publicado: (2013)

Characterization of a novel STAT 2 knock-out hamster model of Crimean-Congo hemorrhagic fever virus pathogenesis
por: Ranadheera, Charlene, et al.
Publicado: (2020)

Therapeutically Administered Ribonucleoside Analogue MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets
por: Cox, Robert M., et al.
Publicado: (2020)

Comparison of the Pathogenicity of Nipah Virus Isolates from Bangladesh and Malaysia in the Syrian Hamster
por: DeBuysscher, Blair L., et al.
Publicado: (2013)

Use of Favipiravir to Treat Lassa Virus Infection in Macaques
por: Rosenke, Kyle, et al.
Publicado: (2018)

Rapid Nipah virus entry into the central nervous system of hamsters via the olfactory route
por: Munster, Vincent J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_sco65jjuksb399ar0cgdanlu6s